SAVE THE DATE – Chronic Traumatic Encephalopathy Conference
November 9th & 10th 2017
Boston University, Metcalf Trustee Center,1 Silber Way, 9th floor, Boston, MA 02215
Questions? Contact, Course Manager, Christina DiTerlizzi, email@example.com * 857-364-2140
Registration Will Be Open Soon
The Conference agenda and topics are subject to change
To request reasonable accommodations for a disability please notify firstname.lastname@example.org, in writing, at least two weeks prior to the conference.
Physicians, Psychologists, Researchers, Students
During this two day course participant will learn all aspects of Chronic Traumatic Encephalopathy (CTE) including its pathology, pathophysiology, genetics, biomarkers, imaging, clinical syndromes, clinical criteria, differential diagnosis, implications for the family, and what it is like to live with the disease.
Boston University CTE Website
Click here to learn more about CTE
Through lectures and question and answer sessions, and panel discussion participants at the conclusion of this conference will be able to:
- Describe the history of concussion and CTE
- Identify the pathology of CTE
- Explain the clinical syndrome and criteria of CTE
- Recognize biomechanics of head trauma
- Summarize the mechanisms of CTE
- Describe genetics of CTE
- Describe the co-morbidity and pathology of CTE
- Identify CTE through biomarkers to therapeutics
- Recognize fluid bio markers of CTE in humans
- Recognize imaging biomarkers of CTE in humans
- Discuss differential diagnosis of CTE
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians & Psychologists.
This activity will be approved for 12.75 AMA PRA APA Category Credits™
It is the policy of Boston University School of Medicine Department of Continuing Medical Education, that faculty disclose to program participants any real or apparent conflict of interest. In addition, the faculty is asked to disclose any discussion pertaining to the unapproved use of pharmaceuticals and devices. Complete disclosure information will be available on site in the printed course materials.